APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,551,000 | +4.7% | 694,918 | 0.0% | 0.06% | +24.0% |
Q2 2021 | $3,391,000 | -4.3% | 694,918 | 0.0% | 0.05% | 0.0% |
Q1 2021 | $3,544,000 | -43.2% | 694,918 | -45.2% | 0.05% | -34.2% |
Q4 2020 | $6,242,000 | -88.6% | 1,268,718 | -44.1% | 0.08% | -92.4% |
Q3 2020 | $54,585,000 | -38.0% | 2,268,718 | 0.0% | 1.00% | -38.3% |
Q2 2020 | $87,981,000 | +11.6% | 2,268,718 | 0.0% | 1.62% | -26.5% |
Q1 2020 | $78,861,000 | -24.3% | 2,268,718 | 0.0% | 2.21% | -11.2% |
Q4 2019 | $104,111,000 | – | 2,268,718 | – | 2.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Princeton Global Asset Management LLC | 100 | $417 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |